Recent News Releases
For investor-related news, see our ASX releases here.
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 26, 2016CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has approved AFSTYLA® [Antihemophilic Factor (Recombinant), Single Chain], its novel long-lasting recombinant factor VIII single-chain therapy for adults and children with hemophilia A.
26 May 2016 AFSTYLA is the first and only single-chain product for hemophilia A, specifically designed for long-lasting protection from bleeds with twice-weekly dosing available In clinical...
-
May 24, 2016
PDF VERSION OF PRESS RELEASE Back to overview of Press Releases
-
May 24, 2016
PDF VERSION OF PRESS RELEASE Back to overview of Press Releases
-
May 23, 2016
PDF VERSION OF PRESS RELEASE Back to overview of Press Releases
-
May 16, 2016CSL Behring supports HAE Day through our continued partnership with HAEi & global awareness event sponsorships.
16 May 2016 CSL Behring joins the global HAE community today in recognition of the fifth annual hae day :-), an initiative led by HAEi, the international patient organization for C1-inhibitor...
Filter by Company:
Get our latest news releases in your inbox